Progesterone

Active ingredient: Progesterone

In short: Progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea.

LabelNuCare Pharmaceuticals,Inc.
Label updatedNov 02, 2026

What is Progesterone used for?

Progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea.

âš  Boxed warning (FDA's strongest warning)

Cardiovascular Disorders and Probable Dementia

Estrogens plus progestin therapy should not be used for the prevention of cardiovascular disease or dementia. (See

CLINICAL STUDIES

and

WARNINGS

,

Cardiovascular disorders

and

Probable dementia

.)

The Women’s Health Initiative (WHI) estrogen plus progestin substudy reported increased risks of deep vein thrombosis, pulmonary embolism, stroke and myocardial infarction in postmenopausal women (50 to 79 years of age) during 5.6 years of treatment with daily oral conjugated estrogens (CE) [0.625 mg] combined with medroxyprogesterone acetate (MPA) [2.5 mg], relative to placebo.

The WHI Memory Study (WHIMS) estrogen plus progestin ancillary study of the WHI reported an increased risk of developing probable dementia in postmenopausal women 65 years of age or older during 4 years of treatment with daily CE (0.625 mg) combined with MPA (2.5 mg), relative to placebo. It is unknown whether this finding applies to younger postmenopausal women. (See

CLINICAL STUDIES

and

WARNINGS

,

Probable dementia

and

PRECAUTIONS

,

Geriatric Use

.)

Breast Cancer

The WHI estrogen plus progestin substudy also demonstrated an increased risk of invasive breast cancer. (See

CLINICAL STUDIES

and

WARNINGS

,

Malignant neoplasms

,

Breast Cancer

.)

In the absence of comparable data, these risks should be assumed to be similar for other doses of CE and MPA, and other combinations and dosage forms of estrogens and progestins. …

Progesterone dosage

Prevention of Endometrial Hyperplasia

Progesterone capsules should be given as a single daily dose at bedtime, 200 mg orally for 12 days sequentially per 28-day cycle, to a postmenopausal woman with a uterus who is receiving daily conjugated estrogens tablets.

Treatment of Secondary Amenorrhea

Progesterone capsules may be given as a single daily dose of 400 mg at bedtime for 10 days.

Some women may experience difficulty swallowing progesterone capsules. For these women, progesterone capsules should be taken with a glass of water while in the standing position.

Warnings & precautions

Do not take this medicine if: Progesterone capsules should not be used in women with any of the following conditions:

Progesterone capsules should not be used in patients with known hypersensitivity to its ingredients. Progesterone capsules contain peanut oil and should never be used by patients allergic to peanuts.

Undiagnosed abnormal genital bleeding.

Known, suspected, or history of breast cancer.

Active deep vein thrombosis, pulmonary embolism or history of these conditions.

Active arterial thromboembolic disease (for example, stroke and myocardial infarction), or a history of these conditions.

Known liver dysfunction or disease.

Known or suspected pregnancy.

1. Addition of a progestin when a woman has not had a hysterectomy

Studies of the addition of a progestin for 10 or more days of a cycle of estrogen administration, or daily with estrogen in a continuous regimen, have reported a lowered incidence of endometrial hyperplasia than would be induced by estrogen treatment alone. Endometrial hyperplasia may be a precursor to endometrial cancer.

There are, however, possible risks that may be associated with the use of progestins with estrogens compared with estrogen-alone regimens. These include an increased risk of breast cancer.

2. Fluid Retention

Progesterone may cause some degree of fluid retention. Women with conditions that might be influenced by this factor, such as cardiac or renal dysfunction, warrant careful observation.

3. Dizziness and Drowsiness

Progesterone capsules may cause transient dizziness and drowsiness and should be used with caution when driving a motor vehicle or operating machinery. Progesterone capsules should be taken as a single daily dose at bedtime.

General: This product contains peanut oil and should not be used if you are allergic to peanuts. …

Progesterone side effects

See

BOXED WARNING

,

WARNINGS

and

PRECAUTIONS.

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

In a multicenter, randomized, double-blind, placebo-controlled clinical trial, the effects of progesterone capsules on the endometrium was studied in a total of 875 postmenopausal women. Table 6 lists adverse reactions greater than or equal to 2 percent of women who received cyclic progesterone capsules 200 mg daily (12 days per calendar month cycle) with 0.625 mg conjugated estrogens or placebo.

Progesterone Capsules

200 mg with Conjugated Estrogens 0.625 mg | Placebo

(n=178) | (n=174)

Headache | 31 | 27

Breast Tenderness | 27 | 6

Joint Pain | 20 | 29

Depression | 19 | 12

Dizziness | 15 | 9

Abdominal Bloating | 12 | 5

Hot Flashes | 11 | 35

Urinary Problems | 11 | 9

Abdominal Pain | 10 | 10

Vaginal Discharge | 10 | 3

Nausea / Vomiting | 8 | 7

Worry | 8 | 4

Chest Pain | 7 | 5

Diarrhea | 7 | 4

Night Sweats | 7 | 17

Breast Pain | 6 | 2

Swelling of Hands and Feet | 6 | 9

Vaginal Dryness | 6 | 10

Constipation | 3 | 2

Breast Carcinoma | 2 | <1

Breast Excisional Biopsy | 2 | <1

Cholecystectomy | 2 | <1

Effects

onSecondary

Amenorrhea In a multicenter, randomized, double-blind, placebo-controlled clinical trial, the effects of progesterone capsules on secondary amenorrhea was …

About this medicine

Progesterone capsules contain micronized progesterone for oral administration. Progesterone has a molecular weight of 314.47 and a molecular formula of C

21H

30O

2. Progesterone (pregn-4-ene-3, 20-dione) is a white or creamy white, crystalline powder or colorless crystals practically insoluble in water, soluble in alcohol, acetone and dioxane and sparingly soluble in vegetable oils, melting between 126º and 131ºC. The structural formula is:

Progesterone is synthesized from a starting material from a plant source and is chemically identical to progesterone of human ovarian origin. Progesterone capsules are available in multiple strengths to afford dosage flexibility for optimum management. Progesterone capsules contain 100 mg or 200 mg micronized progesterone USP.

The inactive ingredients for progesterone capsules include: gelatin, glycerin, hypromellose, iron oxide black, lecithin, peanut oil, propylene glycol, titanium dioxide.

How it works: Progesterone capsules are an oral dosage form of micronized progesterone which is chemically identical to progesterone of ovarian origin. …

Disclaimer: This page is for general information only and is not medical advice. It is a condensed summary of the official FDA-approved label — it does not replace the full prescribing information or the advice of your doctor or pharmacist. Always follow your prescriber's instructions and read the medication guide that comes with your medicine.

Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 4884017f-3314-cd26-e063-6294a90a4e7e. Read the full official label on DailyMed.

Related medicines

Levothyroxine Ergocalciferol Estradiol Ethinyl Estradiol and Norethindrone Alendronate Testosterone Thyroid Norethindrone